Literature DB >> 30320153

Generating Loss-of-function iPSC Lines with Combined CRISPR Indel Formation and Reprogramming from Human Fibroblasts.

Andrew M Tidball1, Preethi Swaminathan1, Louis T Dang2, Jack M Parent1,3.   

Abstract

For both disease and basic science research, loss-of-function (LOF) mutations are vitally important. Herein, we provide a simple stream-lined protocol for generating LOF iPSC lines that circumvents the technical challenges of traditional gene-editing and cloning of established iPSC lines by combining the introduction of the CRISPR vector concurrently with episomal reprogramming plasmids into fibroblasts. Our experiments have produced nearly even numbers of all 3 genotypes in autosomal genes. In addition, we provide a detailed approach for maintaining and genotyping 96-well plates of iPSC clones.

Entities:  

Keywords:  CRISPR/Cas9; Cellular reprogramming; Disease modeling; Genome editing; Human fibroblasts; Induced pluripotent stem cells

Year:  2018        PMID: 30320153      PMCID: PMC6178974          DOI: 10.21769/BioProtoc.2794

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing.

Authors:  Ayal Hendel; Eric J Kildebeck; Eli J Fine; Joseph Clark; Niraj Punjya; Vittorio Sebastiano; Gang Bao; Matthew H Porteus
Journal:  Cell Rep       Date:  2014-03-27       Impact factor: 9.423

2.  Temporal analysis of genome alterations induced by single-cell passaging in human embryonic stem cells.

Authors:  Qiang Bai; Jean-Marie Ramirez; Fabienne Becker; Véronique Pantesco; Thierry Lavabre-Bertrand; Outi Hovatta; Jean-Marc Lemaître; Franck Pellestor; John De Vos
Journal:  Stem Cells Dev       Date:  2014-11-25       Impact factor: 3.272

3.  Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities.

Authors:  Nicholas R Forsyth; Antonio Musio; Paolo Vezzoni; A Hamish R W Simpson; Brendon S Noble; Jim McWhir
Journal:  Cloning Stem Cells       Date:  2006

4.  Isolation of single-base genome-edited human iPS cells without antibiotic selection.

Authors:  Yuichiro Miyaoka; Amanda H Chan; Luke M Judge; Jennie Yoo; Miller Huang; Trieu D Nguyen; Paweena P Lizarraga; Po-Lin So; Bruce R Conklin
Journal:  Nat Methods       Date:  2014-02-09       Impact factor: 28.547

5.  A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells.

Authors:  Sara E Howden; Bradley McColl; Astrid Glaser; Jim Vadolas; Steven Petrou; Melissa H Little; Andrew G Elefanty; Edouard G Stanley
Journal:  Stem Cell Reports       Date:  2016-08-04       Impact factor: 7.765

6.  Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing.

Authors:  Andrew M Tidball; Louis T Dang; Trevor W Glenn; Emma G Kilbane; Daniel J Klarr; Joshua L Margolis; Michael D Uhler; Jack M Parent
Journal:  Stem Cell Reports       Date:  2017-08-03       Impact factor: 7.765

7.  Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts.

Authors:  Sara E Howden; John P Maufort; Bret M Duffin; Andrew G Elefanty; Edouard G Stanley; James A Thomson
Journal:  Stem Cell Reports       Date:  2015-11-12       Impact factor: 7.765

  7 in total
  3 in total

1.  CRISPR/Cas9-mediated Precise SNP Editing in Human iPSC Lines.

Authors:  Hanwen Zhang; Siwei Zhang
Journal:  Bio Protoc       Date:  2021-06-20

2.  Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.

Authors:  Aline Yen Ling Wang; Charles Yuen Yung Loh
Journal:  Cell Transplant       Date:  2019-11-14       Impact factor: 4.064

3.  Simultaneous high-efficiency base editing and reprogramming of patient fibroblasts.

Authors:  Sami Jalil; Timo Keskinen; Rocío Maldonado; Joonas Sokka; Ras Trokovic; Timo Otonkoski; Kirmo Wartiovaara
Journal:  Stem Cell Reports       Date:  2021-11-24       Impact factor: 7.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.